Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Laval Innov
LavalPre-Seed–Late Stage
Teewinot Ventures
Pre-Seed–Late Stage
Zhangjiang Hi-Tech incubation ecosystem
ShanghaiPre-Seed–Growth
Oceanpine Capital
BeijingSeries A–Late Stage
5 people
Zhejiang Sino Wisdom Investment Co.,Ltd.
HangzhouSeries A–Late Stage
5 people
Longbow Capital LLP
NorwichSeries C–Late Stage$1.3M – $12.7M
2 people
Vincera Capital
TaipeiSeed–Late Stage$500K – $10M
2 people
ePlanet Capital
San JoseSeed–Late Stage
3 people
HALLEY Venture Partners
San FranciscoSeed–Series C
3 people
Oriza Holdings
SuzhouSeed–Series C
2 people
Japan Asia Investment
TokyoPre-Seed–Late Stage$1M – $10M
1 person
Kenson Ventures, LLC
Menlo ParkSeed–Late Stage$500K – $3M
1 person
Augere Venture
KrakówSeed–Late Stage
2 people
SL Investment Ltd.
SeoulSeries A–Late Stage$500K – $2M
West Virginia Jobs Investment Trust
CharlestonSeed–Late Stage$100K – $1M
Wild Basin Investments
TexasSeed–Growth
2 people
Brandon Capital Partners
MelbourneSeed–Growth
1 person
Nan Fung Life Sciences
Hong KongSeed–Growth
1 person
Harriet Ventures
Series A–Growth$500K – $50M
CBC Group
SingaporeSeed–Late Stage
2 people
Entrepreneurs Fund
LondonSeries A–Growth
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
CDIB Capital
Hong KongSeries A–Series C
Quark Venture Inc.
VancouverSeed–Series C
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.








